Lifecore Biomedical Aktie
WKN: 899376 / ISIN: US5147661046
02.01.2014 22:33:23
|
Landec Q2 Profit Declines, Meets Estimate - Quick Facts
(RTTNews) - Polymer products company Landec Corp. (LNDC), on Thursday reported second-quarter net income available to common stockholders of $3.45 million, or $0.13 per share, compared to $8.91 million, or $0.34 per share in the comparable quarter last year.
On average, five analysts polled by Thomson Reuters expected the company to earn $0.13 per share for the quarter. Analysts estimate typically excludes one-time items.
Meanwhile, total revenue in the quarter rose 5 percent to $120.03 million from $114.65 million in the prior year quarter, while four analysts expected the company to generate revenues of $124.23 million for the quarter.
Looking ahead to fiscal 2014, the company said that as stated in its press release on November 22, 2013, it continues to expect revenues to meet or exceed the original guidance of 6% growth for fiscal 2014 and expects net income to be flat to up 5% compared to fiscal 2013, after excluding the $3.9 million earn out adjustment in fiscal 2013, barring any additional significant negative weather-related events beyond normal historical levels during the remainder of fiscal 2014.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Lifecore Biomedicalmehr Nachrichten
11.04.25 |
NASDAQ Composite Index-Titel Lifecore Biomedical-Aktie: So viel Verlust hätte ein Investment in Lifecore Biomedical von vor einem Jahr bedeutet (finanzen.at) | |
09.04.25 |
Zuversicht in New York: So performt der NASDAQ Composite mittags (finanzen.at) | |
08.04.25 |
Gewinne in New York: NASDAQ Composite am Nachmittag mit Zuschlägen (finanzen.at) | |
08.04.25 |
Gute Stimmung in New York: NASDAQ Composite am Dienstagmittag im Aufwind (finanzen.at) | |
08.04.25 |
Optimismus in New York: NASDAQ Composite legt zum Handelsstart deutlich zu (finanzen.at) | |
04.04.25 |
Zurückhaltung in New York: NASDAQ Composite bricht schlussendlich ein (finanzen.at) | |
04.04.25 |
NASDAQ Composite aktuell: NASDAQ Composite bricht am Nachmittag ein (finanzen.at) | |
04.04.25 |
Schwache Performance in New York: NASDAQ Composite rauscht am Freitagmittag ab (finanzen.at) |
Analysen zu Lifecore Biomedicalmehr Analysen
Aktien in diesem Artikel
Lifecore Biomedical | 5,05 | -9,01% |
|